Clinical Trial Update: SMART Diets for MASLD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SMART Diets targeting metabolic dysfunction-associated steatotic liver disease (MASLD); the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Corewell Health West | Conditions: Metabolic-dysfunction Associated Steatotic Liver Disease | Phase 2 | Status: NOT_YET_RECRUITING